Log in to save to my catalogue

Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis:...

Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis:...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6287588

Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management study

About this item

Full title

Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management study

Publisher

England: BMJ Publishing Group LTD

Journal title

BMJ, 2017-03, Vol.356, p.j1065-j1065

Language

English

Formats

Publication information

Publisher

England: BMJ Publishing Group LTD

More information

Scope and Contents

Contents

Objective To prospectively validate the HERDOO2 rule (Hyperpigmentation, Edema, or Redness in either leg; D-dimer level ≥250 μg/L; Obesity with body mass index ≥30; or Older age, ≥65 years), which states that women with none or one of the criteria can safely discontinue anticoagulants after short term treatment.Design Prospective cohort management...

Alternative Titles

Full title

Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6287588

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6287588

Other Identifiers

ISSN

0959-8138

E-ISSN

1756-1833,1468-5833

DOI

10.1136/bmj.j1065

How to access this item